Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: An in-silico approach
- DOI
- 10.1016/j.amolm.2024.100058
- Published
- 2025-06
- Container
- Aspects of Molecular Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.amolm.2024.100058,
title = {Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: An in-silico approach},
author = {Uddalak Das and Lavanya Chandramouli and Akshay Uttarkar and Jitendra Kumar and Vidya Niranjan},
year = {2025},
journal = {Aspects of Molecular Medicine},
doi = {10.1016/j.amolm.2024.100058},
url = {https://doi.org/10.1016/j.amolm.2024.100058}
}RIS
TY - JOUR TI - Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: An in-silico approach AU - Uddalak Das AU - Lavanya Chandramouli AU - Akshay Uttarkar AU - Jitendra Kumar AU - Vidya Niranjan PY - 2025 JO - Aspects of Molecular Medicine DO - 10.1016/j.amolm.2024.100058 UR - https://doi.org/10.1016/j.amolm.2024.100058 ER -
APA
Das, U., Chandramouli, L., Uttarkar, A., Kumar, J., & Niranjan, V. (2025). Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: An in-silico approach. Aspects of Molecular Medicine. https://doi.org/10.1016/j.amolm.2024.100058
Source records
- crossref · retrieved 2026-09-26T18:20:06.075Z